Amyvid: Clinical Trials

9 trials of Amyvid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 not yet recruiting. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 8, Not yet recruiting 1

Follow Amyvid: new trials by email Literature Review of Amyvid trials Research Report on Amyvid

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset
Phase 1Not yet recruitingColumbia University62027-08-012026-05-13
Plasma P-tau2017 and Quantitative Amyloid PET Imaging
Amyvid - Alzheimer Disease
Phase 1CompletedInvicro1402021-08-272025-02-28
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
[18F]T807 - Alzheimer's Disease (AD)
Phase 1CompletedMolecular NeuroImaging162015-01-012017-03-08
Florbetapir Calibration to the Centiloid Scale
Florbetapir (18F), 11C-PiB - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals352014-04-012017-03-09
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
[18F]T807 ([18F]MNI-777) - Alzheimer's Disease (AD), Parkinson's Disease (PD)
Phase 1CompletedMolecular NeuroImaging162014-02-012016-12-16
A Study of Florbetapir (18F) in Japanese Healthy Volunteers
florbetapir (18F) - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals72012-08-012013-09-19
A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers
florbetapir F 18 - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals252008-04-012012-05-10
A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
florbetapir F 18 - Alzheimer Disease
Phase 1CompletedAvid Radiopharmaceuticals202008-03-012012-06-18
A Study of 18F-AV-45 in Healthy Volunteers
florbetapir F 18 - Alzheimer Disease
Phase 1CompletedAvid Radiopharmaceuticals92007-10-012012-05-18

Conditions studied

Alzheimer Disease (9)  ·  Chronic Traumatic Encephalopathy (1)  ·  Parkinson Disease (1)  ·  Pick Disease of the Brain (1)  ·  Supranuclear Palsy, Progressive (1)  ·  Tauopathies (1)

Sponsors

Avid Radiopharmaceuticals (5)  ·  Molecular NeuroImaging (2)  ·  Columbia University (1)  ·  Invicro (1)

Countries

United States (8)  ·  Australia (1)  ·  Japan (1)

Top investigators

Danna Jennings, MD (2)  ·  David Russell (1)  ·  Grace McIlvain, PhD (1)

Results publications

PMID 27908967